Marshall Wace Portfolio holdings
AUM
$84.1B
1-Year Return
27.54%
This Quarter Return
+10.81%
1 Year Return
+27.54%
3 Year Return
+105.03%
5 Year Return
+179.94%
10 Year Return
+445.45%
AUM
$60.4B
AUM Growth
+$8.03B
(+15%)
Cap. Flow
+$2.59B
Cap. Flow
% of AUM
4.29%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
2,708
New
760
Increased
647
Reduced
624
Closed
461
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$433M |
| 2 |
Goldman Sachs
GS
|
$402M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$366M |
| 4 |
Procter & Gamble
PG
|
$331M |
| 5 |
Coca-Cola
KO
|
$299M |
Top Sells
| 1 |
Walmart
WMT
|
$420M |
| 2 |
Constellation Brands
STZ
|
$371M |
| 3 |
Meta Platforms (Facebook)
META
|
$312M |
| 4 |
Kenvue
KVUE
|
$293M |
| 5 |
JPMorgan Chase
JPM
|
$281M |
Sector Composition
| 1 | Technology | 17.87% |
| 2 | Healthcare | 14.24% |
| 3 | Consumer Discretionary | 13.82% |
| 4 | Financials | 8.32% |
| 5 | Communication Services | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Murphy Oil
MUR
$3.56B
| $49.6M | 0.08% |
1,085,801
+43,672
| +4% | +$2M |
|
227
Rexford Industrial Realty
REXR
$10.2B
| $49.6M | 0.08% |
986,303
+879,677
| +825% | +$44.2M |
|
228
Revolution Medicines
RVMD
$7.57B
| $49.5M | 0.08% |
1,535,940
+327,011
| +27% | +$10.5M |
|
229
Williams Companies
WMB
$69.9B
| $49.2M | 0.07% |
1,262,467
+1,228,781
| +3,648% | +$47.9M |
|
230
NRG Energy
NRG
$28.6B
| $48.9M | 0.07% |
+722,235
| New | +$48.9M |
|
231
Cisco
CSCO
$264B
| $48.7M | 0.07% |
976,578
+712,345
| +270% | +$35.6M |
|
232
Flutter Entertainment
FLUT
$51.9B
| $48.4M | 0.07% |
+245,154
| New | +$48.4M |
|
233
Syndax Pharmaceuticals
SNDX
$1.47B
| $48.4M | 0.07% |
2,032,059
-69,852
| -3% | -$1.66M |
|
234
Futu Holdings
FUTU
$26.1B
| $48M | 0.07% |
886,945
+78,157
| +10% | +$4.23M |
|
235
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $48M | 0.07% |
1,168,531
+986,331
| +541% | +$40.5M |
|
236
Affiliated Managers Group
AMG
$6.54B
| $47.9M | 0.07% |
286,248
-52,401
| -15% | -$8.78M |
|
237
UnitedHealth
UNH
$286B
| $47.5M | 0.07% |
96,058
-152,100
| -61% | -$75.2M |
|
238
Bristol-Myers Squibb
BMY
$96B
| $47.4M | 0.07% |
+874,184
| New | +$47.4M |
|
239
Icon
ICLR
$13.6B
| $47M | 0.07% |
139,768
+18,346
| +15% | +$6.16M |
|
240
Avantor
AVTR
$9.07B
| $46.7M | 0.07% |
1,825,944
+1,063,671
| +140% | +$27.2M |
|
241
Verizon
VZ
$187B
| $46.4M | 0.07% |
1,105,602
-915,885
| -45% | -$38.4M |
|
242
Ecolab
ECL
$77.6B
| $46.2M | 0.07% |
200,206
+144,398
| +259% | +$33.3M |
|
243
Envista
NVST
$3.54B
| $46M | 0.07% |
2,152,721
-1,413,739
| -40% | -$30.2M |
|
244
Urban Outfitters
URBN
$6.35B
| $45.9M | 0.07% |
1,058,046
-616,284
| -37% | -$26.8M |
|
245
argenx
ARGX
$45.9B
| $45.9M | 0.07% |
116,635
-9,036
| -7% | -$3.56M |
|
246
Lockheed Martin
LMT
$108B
| $45.8M | 0.07% |
100,712
-117,531
| -54% | -$53.5M |
|
247
SBA Communications
SBAC
$21.2B
| $45.3M | 0.07% |
+209,200
| New | +$45.3M |
|
248
Ultragenyx Pharmaceutical
RARE
$3.07B
| $45.2M | 0.07% |
968,990
-520,496
| -35% | -$24.3M |
|
249
Invesco Senior Loan ETF
BKLN
$6.98B
| $44.4M | 0.07% |
2,100,700
+900,800
| +75% | +$19.1M |
|
250
Royalty Pharma
RPRX
$15.6B
| $44.2M | 0.07% |
1,455,900
+15,857
| +1% | +$482K |
|